Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
15%

OVERLAP
BY WEIGHT
14

# OF OVERLAPPING
HOLDINGS
CANC
56
HOLDINGS
25%
ALSO IN BBP
BBP
70
HOLDINGS
23%
ALSO IN CANC
SECTOR DRIFT (CANC minus BBP)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in BBP
Overlap
ZAI LAB LTD. UNSPONSORED ADR 1.9% 1.5% 1.5%
BRIDGEBIO PHARMA, INC. 2.6% 1.4% 1.4%
HALOZYME THERAPEUTICS INC 3.0% 1.4% 1.4%
EXELIXIS INC 2.8% 1.4% 1.4%
IOVANCE BIOTHERAPEUTICS INC 1.6% 1.4% 1.4%
CANC Overweight Relative to BBP
REVOLUTION MEDICINES, INC. 5.5%
COGENT BIOSCIENCES INC 5.0%
MERCK & CO. INC. 4.6%
ELI LILLY & CO 4.4%
NOVARTIS AG 3.6%
BRISTOL-MYERS SQUIBB CO 3.6%
ABBVIE INC 3.5%
JOHNSON & JOHNSON 3.2%
ROCHE HOLDINGS LTD-SPONS ADR 3.1%
GENMAB A/S SPONSORED ADR 2.9%
CANC Underweight Relative to BBP
OMEROS CORP -1.7%
AGIOS PHARMACEUTICALS INC -1.7%
SAREPTA THERAPEUTICS INC -1.6%
ULTRAGENYX PHARMACEUTICAL IN -1.6%
CYTOKINETICS INC -1.6%
ARROWHEAD PHARMACEUTICALS, INC. -1.6%
GERON CORP -1.6%
RHYTHM PHARMACEUTICALS, INC. -1.6%
KRYSTAL BIOTECH, INC. -1.6%
CRISPR THERAPEUTICS AG -1.6%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY